TuHURA Biosciences, Inc. (HURA) vs MediciNova, Inc. (MNOV)
TuHURA Biosciences, Inc. and MediciNova, Inc. are both Biotechnology companies. TuHURA Biosciences, Inc. and MediciNova, Inc. are of similar size ($133.8M and $132.9M). TuHURA Biosciences, Inc. has the higher net margin (0.00% vs −1,168.3%) and the lower return on invested capital (−74.2% vs −62.5%). Across the 14 metrics below, MediciNova, Inc. leads on 9 and TuHURA Biosciences, Inc. on 5.
Valuation
Profitability
| Metric | HURA | MNOV | Biotechnology median |
|---|---|---|---|
| Gross margin | 0.00% | 37.76% | 65.16% |
| Operating margin | 0.00% | (1,287.53%) | 0.00% |
| Net margin | 0.00% | (1,168.31%) | 0.00% |
| Free cash flow margin | 0.00% | (991.31%) | 0.00% |
| Return on equity | (163.84%) | (25.56%) | (57.72%) |
| Return on assets | (92.31%) | (23.83%) | (49.22%) |
| Return on invested capital | (74.20%) | (62.48%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack